Report overview
Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of health care is known as a nosocomial, or hospital acquired, infection. The infection may occur in a postoperative wound or as a complication unrelated to the disease or condition.
This report contains market size and forecasts of Hospital Acquired Infections Control in Global, including the following market information:
Global Hospital Acquired Infections Control Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hospital Acquired Infections Control market was valued at 5867.2 million in 2021 and is projected to reach US$ 7101.9 million by 2028, at a CAGR of 2.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Education Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hospital Acquired Infections Control include AstraZeneca, GlaxoSmithKline, Merck and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hospital Acquired Infections Control companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital Acquired Infections Control Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hospital Acquired Infections Control Market Segment Percentages, by Type, 2021 (%)
Education
Medical Device Disinfection
Screening
Environmental Control
Global Hospital Acquired Infections Control Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hospital Acquired Infections Control Market Segment Percentages, by Application, 2021 (%)
General Hospital
Infectious Disease Hospital
Global Hospital Acquired Infections Control Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hospital Acquired Infections Control Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital Acquired Infections Control revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hospital Acquired Infections Control revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
GlaxoSmithKline
Merck
Pfizer
